-
at the interface of preclinical research, academic leukodystrophy expertise and patient-oriented therapy development. Your work will include: Performing longitudinal natural-history studies in
-
used to model leukodystrophies because of their genetic tractability and the ability to study early brain development. To strengthen their use as preclinical models, this project will develop outcome
-
POLARIS doctoral network POLARIS is a European Marie Skłodowska-Curie Doctoral Network focused on accelerating therapy development for leukodystrophies: rare genetic disorders affecting the brain's
-
will independently contribute to the design and implementation of a multi-site, international research project. Your work will include qualitative and quantitative research, development and validation
-
this project, you will develop new image analysis methodologies for less invasive and non-invasive quantitative brain PET studies using LAFOV PET/CT. You will work on model-independent kinetic analysis methods
-
Tübingen, Germany, with academic enrolment through the Eberhard Karls University of Tübingen. You will pursue a PhD degree in a relevant discipline. You will contribute to the development and validation
-
studies across multiple disease areas. Your responsibilities include: developing quantitative image analysis methods to improve image quality in ^89Zr-immunoPET; applying advanced analysis techniques
-
focused on accelerating therapy development for leukodystrophies: rare genetic disorders affecting the brain's white matter. The network aims to strengthen the full translational pathway from disease
-
pursue a PhD degree in a relevant discipline. You will contribute to the development and validation of liquid biomarkers for leukodystrophies. You will work with iPSC-derived disease models and patient
-
on accelerating therapy development for leukodystrophies: rare genetic disorders affecting the brain's white matter. The network aims to strengthen the full translational pathway, from understanding disease